A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector

Nicole, Keule; Johnson, Yasmina; Renier, Coetzee.
South African Family Practice ; 64(3): 1-7, 19 May 2022. Tables
Artículo en Inglés | AIM | ID: biblio-1380566

Documentos relacionados

  1. A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector.
  2. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
  3. Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study.
  4. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
  5. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
  6. Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019.
  7. Effects of sodium valproate and levetiracetam on posterior segment parameters in children with epilepsy.
  8. Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: An observation study in northwest China.
  9. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
  10. How Reliable Are Serum Levetiracetam Levels to Be Used as a Primary Endpoint?